Unitinib 400 mg Capsule

Unitinib 400 mg Capsule belongs to the tyrosine kinase inhibitor class and works by blocking specific abnormal proteins involved in cancer-cell growth. It is used in conditions such as chronic myeloid leukemia and gastrointestinal stromal tumors, with additional indications depending on the patient’s diagnosis. The dosage and treatment duration are determined by the treating specialist according to the disease and clinical response. Regular medical monitoring may be required because treatment can cause edema, nausea, diarrhea, muscle cramps, fatigue, and changes in blood counts.

Unitinib 400 mg, Unitinib 400 mg Capsule, Imatinib Mesylate 400 mg Capsule, Imatinib 400 mg Capsule, Imatinib Mesylate Capsule, Unitinib Imatinib 400 mg, Targeted Anticancer Capsule